Exploring the therapeutic potential of a novel series of imidazothiadiazoles targeting focal adhesion kinase (FAK) for pancreatic cancer treatment: Synthesis, mechanistic Insights and promising antitumor and safety profile
D. Carbone, C. Pecoraro, F. Sciano, F. Terrana, G. Xu, C. Bergonzini, M. S. F. Roeten, S. M. Cascioferro, G. Cirrincione, P. Diana, E. Giovannetti, B. Parrino
This study identifies compound 10l as a potent FAK inhibitor with antitumor activity and safety in pancreatic cancer models.
bioRxiv · May 27, 2024 · PreprintCancer Biology